GE HealthCare Expands Contrast Media Portfolio with Launch MRI Agent Pixxoscan
27 Apr 2023 //
BUSINESSWIRE
Strides`s Generic Gadobutrol Receives Approval in the U.S.
17 Nov 2022 //
FDA
The Journal of the American College of Cardiology Publishes Data for Gadavist®
02 Oct 2020 //
BUSINESSWIRE
CORRECTING and REPLACING FDA Approves Gadavist® Imaging Bulk Package
13 Aug 2020 //
BUSINESSWIRE
FDA approves Bayer`s Gadavist MRI agent to help spot coronary artery disease
15 Jul 2019 //
FIERCE BIOTECH
FDA approves Bayer`s Gadavist® (gadobutrol) injection as first contrast agent
29 Apr 2016 //
PR NEWS WIRE
Bayer’s Gadovist (Gadobutrol) Approved in Japan For Magnetic Resonance Imaging
31 Mar 2015 //
BAYER